Serological and biochemical study of hepatitis B patients, a report from the southeast of Iran
暂无分享,去创建一个
M. Delaramnasab | I. Shahramian | A. Bazi | Omolbanin Sargazi-aval | E. Sharafi | Daryoush Rostami | Omolbanin Sargazi-Aval | Elham Sharafi
[1] M. Mohammadzadeh,et al. The Estimation of Economic Burden of Hepatitis C Virus Infection in Iran , 2017, Iranian journal of public health.
[2] M. Washington,et al. Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral Therapy , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[3] N. Xia,et al. Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase , 2017, Scientific Reports.
[4] Qing Lin,et al. Immune response- and viral control-related pathways in the progression of chronic hepatitis B. , 2017, Microbial pathogenesis.
[5] A. Olokoba,et al. Prevalence of antibody to hepatitis B core antigen among hepatitis B surface antigen-negative blood donors in Ilorin, Nigeria: A cross-sectional study. , 2017, Malawi medical journal : the journal of Medical Association of Malawi.
[6] Guo Yong Hao,et al. The prevalence of hepatitis B infection in central China: An adult population‐based serological survey of a large sample size , 2017, Journal of medical virology.
[7] P. Pineau,et al. Widespread geographical disparities in chronic hepatitis B virus infection in Algeria , 2017, Archives of Virology.
[8] E. Sokal,et al. Hepatitis B: changing epidemiology and interventions , 2016, Archives of Disease in Childhood.
[9] M. Karamian,et al. Seroprevalence and Risk Factors for Hepatitis B in an Adult Population: The First Report from Birjand, South Khorasan, Iran , 2016, Hepatitis monthly.
[10] S. Alavian,et al. Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-Analysis , 2016, Hepatitis monthly.
[11] E. Miri-Moghaddam,et al. Characteristics of Seropositive Hepatitis B and C Thalassemia Major Patients in South-East of Iran , 2016 .
[12] M. Zahedi,et al. Seroprevalence of hepatitis B before marriage: a study on marriage candidates in the Southeast of Iran; is it worthy of consideration? , 2015, Archives of Iranian medicine.
[13] Z. Sharifi. Natural History of Chronic Hepatitis B Virus Infection Based on Laboratory Testing , 2014, Iranian journal of public health.
[14] L. Nguyen,et al. Systematic review with meta‐analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase ≤40 IU/L and significant hepatic fibrosis , 2014, Alimentary pharmacology & therapeutics.
[15] M. Ghayour-Mobarhan,et al. The Prevalence of Hepatitis B Virus Infection in Mashhad, Iran: A Population-Based Study , 2013, Iranian Red Crescent medical journal.
[16] M. A. Toori,et al. Hepatitis B Infection among high risk population: a seroepidemiological survey in Southwest of Iran , 2012, BMC Infectious Diseases.
[17] H. Poustchi,et al. Seroprevalence of Hepatitis B Surface Antigen and Anti Hepatitis C Antibody in Zahedan City, Iran: A Population-Based Study , 2012, Hepatitis monthly.
[18] A. Nejatizadeh,et al. Significance of blood-related high-risk behaviors and horizontal transmission of hepatitis B Virus in Iran , 2011, Archives of Virology.
[19] R. Malekzadeh,et al. The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. , 2009, Archives of Iranian medicine.